The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 02, 2012

Filed:

Dec. 30, 2008
Applicants:

Christopher R. Trotta, Somerset, NJ (US);

Sergey Paushkin, Belle Mead, NJ (US);

Inventors:

Christopher R. Trotta, Somerset, NJ (US);

Sergey Paushkin, Belle Mead, NJ (US);

Assignee:

PTC Therapeutics, Inc., South Plainfield, NJ (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 14/00 (2006.01); C12N 9/16 (2006.01); C12P 21/00 (2006.01); C12Q 1/44 (2006.01);
U.S. Cl.
CPC ...
Abstract

The invention provides human protein complexes with endonuclease activity, including tRNA splicing endonuclease activity and 3' end pre-mRNA endonuclease activity, and pre-ribosomal RNA cleavage activity. The invention also provides a splice variant of human Sen2, and human protein complexes comprising the variant. The invention provides human protein complexes with pre-ribosomal RNA cleavage activity. The invention also provides antibodies that immunospecifically bind to a complex described herein or a component thereof, and uses of such antibodies. The present invention also provides methods of preparing and purifying the complexes and uses of the complexes inter alia, in screening, diagnosis, and therapy. The present invention further provides methods of identifying a compound that modulates the expression of a component of a complex described herein, the formation of a complex described herein or the activity of a complex described herein, and methods of preventing, treating, managing or ameliorating a disorder, such as a proliferative disorder, or a symptom thereof utilizing such a compound.


Find Patent Forward Citations

Loading…